Vaccination to prevent type 1 diabetes

Expert Review of Vaccines

Volumn 1, Issue 1, 2002, Pages 25-28

  Von Herrath, Matthias G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Bystander supression; GAD; IL 10; IL 4; Immune based intervention; Insulin B; Regulatory cells; Therapy; Type 1 diabetes; Vaccination

Indexed keywords

AUTOANTIGEN; CYCLOSPORIN A; CYTOKINE; DNA VACCINE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; DRUG TOLERANCE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 1; HUMANS; VACCINATION;

EID: 0037838637     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.1.1.25     Document Type: Article

References (19)

1. Carel JC, Boitard Eisenbarth G, Bach JF, Bougneres, PF. Cyclosporin delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children. J. Autoimmun. 9(6), 739-745 (1996).
2. Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M, TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis. APMIS 105(4), 257-263 (1997).
3. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 85(3), 307-310 (1996).
4. Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in asscciadon with rumor necrosis factor alpha antagonism: By what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44(9), 1977-1983 (2001).
5. Chatenoud L, Thervet E, Primo J, Bach JF. Anticd3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl Acad Sci. USA 91(1), 123-127 (1994).
6. Chatenoud L, Primo J, Bach JE Cd3 antibody-induced dominant self tolerance in overtly diabetic nod mice. J. Immunol. 158(6), 2947-2954 (1997).
7. Homann D, Holz A, Bot A et al Autoreactive cd4+ lymphocytes protect from autoimmune diabetes via bystander suppression using the il-4/stat6 pathway. Immunity 11, 463-472 (1999).
8. Abbas AK Die and let, live: Eliminating dangerous lymphocytes. Cell 84, 655-657 (1996).
9. Chen Y, Inobe J, Marks R et al. Peripheral deletion of antigen-reactive T-cells in oral tolerance. Nature 376, 177-180 (1995).
10. Benson JM, Campbell KA, Guan Z et al T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen [in process citation]. J. Clin. Invest. 106(8), 1031-1038 (2000).
11. Aichele P, Brduscha-Riem K, Oehen S et al. Peptide antigen treatment of naive and virus-immune mice: Antigen-specific tolerance versus immunopathology. Immunity 6(5), 519-529 (1997).
12. von Herrath MG, Coon B, Wolfe T. Tolerance induction with agonist peptides recognized by autoaggressive lymphocytes is transient: Therapeutic potential for Type 1 diabetes is limited and depends on time-point of administration, choice of epitope and adjuvant. J. Autoimmum 16(3), 193-199 (2001).
13. Hanninen A, Martinez NR, Davey GM, Heath WR, Harrison LC. Transient blockade of cd40 ligand dissociates pathogenic from protective mucosal immunity. J. Clin. Invest. 109(2), 261-267 (2002).
14. Maron R, Blogg NS, Polanski M, Hancock W, Weiner HL. Oral tolerance to insulin and the insulin b-chain: Cell lines and cytokine patterns. Ann. NY Acad Sci. 778(346), 357 (1996).
15. Coon B, An LL, Whitton JL, von Herrath, MG. DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104, 189-194 (1999).
16. von Herrath MG, Whitton JL. DNA vaccination to treat autoimmune diabetes. Ann. Med. 32, 285-292 (2000).
17. Wolfe T, Bot A, Hughes A et al. Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent Type 1 diabetes - addition of il-4 increases safety. Eur. J. Immunol. In press (2001).
18. Zang JA, Davidson L, Eisenbarth G, Weiner H. Suppression of diabetes in nod mice by oral administration of porcine insulin. Proc. Natl Acad Sci. USA 88, 10252-10256 (1991).
19. Bot A, Smith D, Bot S et al. Plasmid vaccination with insulin b chain prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol 167(5),2950-2955 (2001).